Brain Biomarker Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: B382EE37C889EN
Market Monitor Global

Abstracts

Brain Biomarkers are measurable indicators that measure the severity of brain in diseased state.

This report contains market size and forecasts of Brain Biomarker in Global, including the following market information:

Global Brain Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Brain Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biomarker Test Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Brain Biomarker include Philips, Johnson & Johnson, Roche, Seimens, GE, NeuroVista, Qiagen, Lifesign and Natus and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Brain Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Brain Biomarker Market Segment Percentages, by Type, 2021 (%)

• Biomarker Test Kits
• Biomarker Analyzers

Global Brain Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Brain Biomarker Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories

Global Brain Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Brain Biomarker Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Brain Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Brain Biomarker revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Philips
• Johnson & Johnson
• Roche
• Seimens
• GE
• NeuroVista
• Qiagen
• Lifesign
• Natus
• BrainScope

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Brain Biomarker Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Brain Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRAIN BIOMARKER OVERALL MARKET SIZE

2.1 Global Brain Biomarker Market Size: 2021 VS 2028
2.2 Global Brain Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Brain Biomarker Players in Global Market
3.2 Top Global Brain Biomarker Companies Ranked by Revenue
3.3 Global Brain Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Brain Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Brain Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Biomarker Players in Global Market
  3.6.1 List of Global Tier 1 Brain Biomarker Companies
  3.6.2 List of Global Tier 2 and Tier 3 Brain Biomarker Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Brain Biomarker Market Size Markets, 2021 & 2028
  4.1.2 Biomarker Test Kits
  4.1.3 Biomarker Analyzers
4.2 By Type - Global Brain Biomarker Revenue & Forecasts
  4.2.1 By Type - Global Brain Biomarker Revenue, 2017-2022
  4.2.2 By Type - Global Brain Biomarker Revenue, 2023-2028
  4.2.3 By Type - Global Brain Biomarker Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Brain Biomarker Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Diagnostic Laboratories
5.2 By Application - Global Brain Biomarker Revenue & Forecasts
  5.2.1 By Application - Global Brain Biomarker Revenue, 2017-2022
  5.2.2 By Application - Global Brain Biomarker Revenue, 2023-2028
  5.2.3 By Application - Global Brain Biomarker Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Brain Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Brain Biomarker Revenue & Forecasts
  6.2.1 By Region - Global Brain Biomarker Revenue, 2017-2022
  6.2.2 By Region - Global Brain Biomarker Revenue, 2023-2028
  6.2.3 By Region - Global Brain Biomarker Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Brain Biomarker Revenue, 2017-2028
  6.3.2 US Brain Biomarker Market Size, 2017-2028
  6.3.3 Canada Brain Biomarker Market Size, 2017-2028
  6.3.4 Mexico Brain Biomarker Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Brain Biomarker Revenue, 2017-2028
  6.4.2 Germany Brain Biomarker Market Size, 2017-2028
  6.4.3 France Brain Biomarker Market Size, 2017-2028
  6.4.4 U.K. Brain Biomarker Market Size, 2017-2028
  6.4.5 Italy Brain Biomarker Market Size, 2017-2028
  6.4.6 Russia Brain Biomarker Market Size, 2017-2028
  6.4.7 Nordic Countries Brain Biomarker Market Size, 2017-2028
  6.4.8 Benelux Brain Biomarker Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Brain Biomarker Revenue, 2017-2028
  6.5.2 China Brain Biomarker Market Size, 2017-2028
  6.5.3 Japan Brain Biomarker Market Size, 2017-2028
  6.5.4 South Korea Brain Biomarker Market Size, 2017-2028
  6.5.5 Southeast Asia Brain Biomarker Market Size, 2017-2028
  6.5.6 India Brain Biomarker Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Brain Biomarker Revenue, 2017-2028
  6.6.2 Brazil Brain Biomarker Market Size, 2017-2028
  6.6.3 Argentina Brain Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Brain Biomarker Revenue, 2017-2028
  6.7.2 Turkey Brain Biomarker Market Size, 2017-2028
  6.7.3 Israel Brain Biomarker Market Size, 2017-2028
  6.7.4 Saudi Arabia Brain Biomarker Market Size, 2017-2028
  6.7.5 UAE Brain Biomarker Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Philips
  7.1.1 Philips Corporate Summary
  7.1.2 Philips Business Overview
  7.1.3 Philips Brain Biomarker Major Product Offerings
  7.1.4 Philips Brain Biomarker Revenue in Global Market (2017-2022)
  7.1.5 Philips Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Brain Biomarker Major Product Offerings
  7.2.4 Johnson & Johnson Brain Biomarker Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Brain Biomarker Major Product Offerings
  7.3.4 Roche Brain Biomarker Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 Seimens
  7.4.1 Seimens Corporate Summary
  7.4.2 Seimens Business Overview
  7.4.3 Seimens Brain Biomarker Major Product Offerings
  7.4.4 Seimens Brain Biomarker Revenue in Global Market (2017-2022)
  7.4.5 Seimens Key News
7.5 GE
  7.5.1 GE Corporate Summary
  7.5.2 GE Business Overview
  7.5.3 GE Brain Biomarker Major Product Offerings
  7.5.4 GE Brain Biomarker Revenue in Global Market (2017-2022)
  7.5.5 GE Key News
7.6 NeuroVista
  7.6.1 NeuroVista Corporate Summary
  7.6.2 NeuroVista Business Overview
  7.6.3 NeuroVista Brain Biomarker Major Product Offerings
  7.6.4 NeuroVista Brain Biomarker Revenue in Global Market (2017-2022)
  7.6.5 NeuroVista Key News
7.7 Qiagen
  7.7.1 Qiagen Corporate Summary
  7.7.2 Qiagen Business Overview
  7.7.3 Qiagen Brain Biomarker Major Product Offerings
  7.7.4 Qiagen Brain Biomarker Revenue in Global Market (2017-2022)
  7.7.5 Qiagen Key News
7.8 Lifesign
  7.8.1 Lifesign Corporate Summary
  7.8.2 Lifesign Business Overview
  7.8.3 Lifesign Brain Biomarker Major Product Offerings
  7.8.4 Lifesign Brain Biomarker Revenue in Global Market (2017-2022)
  7.8.5 Lifesign Key News
7.9 Natus
  7.9.1 Natus Corporate Summary
  7.9.2 Natus Business Overview
  7.9.3 Natus Brain Biomarker Major Product Offerings
  7.9.4 Natus Brain Biomarker Revenue in Global Market (2017-2022)
  7.9.5 Natus Key News
7.10 BrainScope
  7.10.1 BrainScope Corporate Summary
  7.10.2 BrainScope Business Overview
  7.10.3 BrainScope Brain Biomarker Major Product Offerings
  7.10.4 BrainScope Brain Biomarker Revenue in Global Market (2017-2022)
  7.10.5 BrainScope Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Brain Biomarker Market Opportunities & Trends in Global Market
Table 2. Brain Biomarker Market Drivers in Global Market
Table 3. Brain Biomarker Market Restraints in Global Market
Table 4. Key Players of Brain Biomarker in Global Market
Table 5. Top Brain Biomarker Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Brain Biomarker Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Brain Biomarker Revenue Share by Companies, 2017-2022
Table 8. Global Companies Brain Biomarker Product Type
Table 9. List of Global Tier 1 Brain Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Brain Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Brain Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Brain Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Brain Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Brain Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Brain Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Brain Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Brain Biomarker Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Brain Biomarker Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Brain Biomarker Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Brain Biomarker Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Brain Biomarker Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Brain Biomarker Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Brain Biomarker Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Brain Biomarker Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Brain Biomarker Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Brain Biomarker Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Brain Biomarker Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Brain Biomarker Revenue, (US$, Mn), 2023-2028
Table 30. Philips Corporate Summary
Table 31. Philips Brain Biomarker Product Offerings
Table 32. Philips Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Brain Biomarker Product Offerings
Table 35. Johnson & Johnson Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche Brain Biomarker Product Offerings
Table 38. Roche Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 39. Seimens Corporate Summary
Table 40. Seimens Brain Biomarker Product Offerings
Table 41. Seimens Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 42. GE Corporate Summary
Table 43. GE Brain Biomarker Product Offerings
Table 44. GE Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 45. NeuroVista Corporate Summary
Table 46. NeuroVista Brain Biomarker Product Offerings
Table 47. NeuroVista Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 48. Qiagen Corporate Summary
Table 49. Qiagen Brain Biomarker Product Offerings
Table 50. Qiagen Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 51. Lifesign Corporate Summary
Table 52. Lifesign Brain Biomarker Product Offerings
Table 53. Lifesign Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 54. Natus Corporate Summary
Table 55. Natus Brain Biomarker Product Offerings
Table 56. Natus Brain Biomarker Revenue (US$, Mn), (2017-2022)
Table 57. BrainScope Corporate Summary
Table 58. BrainScope Brain Biomarker Product Offerings
Table 59. BrainScope Brain Biomarker Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Brain Biomarker Segment by Type in 2021
Figure 2. Brain Biomarker Segment by Application in 2021
Figure 3. Global Brain Biomarker Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Brain Biomarker Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Brain Biomarker Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Biomarker Revenue in 2021
Figure 8. By Type - Global Brain Biomarker Revenue Market Share, 2017-2028
Figure 9. By Application - Global Brain Biomarker Revenue Market Share, 2017-2028
Figure 10. By Region - Global Brain Biomarker Revenue Market Share, 2017-2028
Figure 11. By Country - North America Brain Biomarker Revenue Market Share, 2017-2028
Figure 12. US Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Brain Biomarker Revenue Market Share, 2017-2028
Figure 16. Germany Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 17. France Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Brain Biomarker Revenue Market Share, 2017-2028
Figure 24. China Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 28. India Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Brain Biomarker Revenue Market Share, 2017-2028
Figure 30. Brazil Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Brain Biomarker Revenue Market Share, 2017-2028
Figure 33. Turkey Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Brain Biomarker Revenue, (US$, Mn), 2017-2028
Figure 37. Philips Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Seimens Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GE Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. NeuroVista Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Qiagen Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lifesign Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Natus Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BrainScope Brain Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)